Oxidative Stress Management in Cardiorenal Diseases: Focus on Novel Antidiabetic Agents, Finerenone, and Melatonin.

Life (Basel) · 2022 · PMC9605243 · PMID 36295098

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may be significantno p-value reported

Moving to GLP1-RA, another class with proven cardiorenal benefits used solely in patients with type 2 diabetes mellitus, we should state that there may be significant within class variations regarding efficacy, weight loss, and tolerability [ 151 ].

also in 13,097 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.